These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Imaging of medullary thyroid cancer with 131I-MIBG. Endo K; Shiomi K; Kasagi K; Konishi J; Torizuka K; Nakao K; Tanimura H Lancet; 1984 Jul; 2(8396):233. PubMed ID: 6146795 [No Abstract] [Full Text] [Related]
5. Imaging and uptake mechanism of 131I-meta-iodobenzylguanidine in medullary thyroid carcinoma. Oishi S; Sasaki M; Sato T; Hirota Y; Takahashi M Endocrinol Jpn; 1986 Jun; 33(3):309-15. PubMed ID: 2875869 [TBL] [Abstract][Full Text] [Related]
6. Iodine-131 MIBG uptake in metastatic medullary carcinoma of the thyroid. A patient treated with somatostatin. Keeling CA; Basso LV Clin Nucl Med; 1988 Apr; 13(4):260-3. PubMed ID: 2897264 [TBL] [Abstract][Full Text] [Related]
7. Extra-adrenal and metastatic pheochromocytoma: the role of 131I meta-iodobenzylguanidine (131I MIBG) in localization and management. Thompson NW; Allo MD; Shapiro B; Sisson JC; Beierwaltes W World J Surg; 1984 Aug; 8(4):605-11. PubMed ID: 6148810 [No Abstract] [Full Text] [Related]
11. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA. Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436 [TBL] [Abstract][Full Text] [Related]
12. [The evaluation of 123I-MIBG scintigraphy in medullary thyroid carcinoma (MTC)]. Ahuja S; Koppenhagen K; Ernst H Strahlenther Onkol; 1990 Nov; 166(11):718-21. PubMed ID: 2260009 [TBL] [Abstract][Full Text] [Related]
13. Scintigraphic portrayal of the syndrome of multiple endocrine neoplasia type-2B. Yobbagy JJ; Levatter R; Sisson JC; Shulkin BL; Polley T Clin Nucl Med; 1988 Jun; 13(6):433-7. PubMed ID: 2900089 [TBL] [Abstract][Full Text] [Related]
14. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome. Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305 [TBL] [Abstract][Full Text] [Related]
15. The possible use of radioiodinated metaiodobenzylguanidine (MIBG) in medullary thyroid carcinoma. Troncone L; Rufini V; Maussier ML; Valenza V; Montemaggi P; Legnaioli M Thyroidology; 1988 Apr; (1):45-53. PubMed ID: 2484894 [TBL] [Abstract][Full Text] [Related]
16. Imaging of metastatic medullary carcinoma of the thyroid with 131I-meta-iodobenzyl guanidine. Poston GJ; Thomas AM; Macdonald DW; Karvounaris D; Henderson BL; George P; Lynn JA; Lavender JP Nucl Med Commun; 1986 Apr; 7(4):215-21. PubMed ID: 2873544 [TBL] [Abstract][Full Text] [Related]
17. Iodine 123 metaiodobenzylguanidine radio-guided navigation surgery for recurrent medullary thyroid carcinoma in a girl with multiple endocrine neoplasia type 2B. Shimotake T; Tsuda T; Aoi S; Fumino S; Iwai N J Pediatr Surg; 2005 Oct; 40(10):1643-6. PubMed ID: 16226999 [TBL] [Abstract][Full Text] [Related]
18. The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma. Verga U; Muratori F; Di Sacco G; Banfi F; Libroia A Henry Ford Hosp Med J; 1989; 37(3-4):175-7. PubMed ID: 2576958 [TBL] [Abstract][Full Text] [Related]
19. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers. Jansson S; Tisell LE; Fjälling M; Lindberg S; Jacobsson L; Zachrisson BF Surgery; 1988 Jan; 103(1):11-8. PubMed ID: 2892276 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and therapeutic potential of new radiopharmaceutical agents in medullary thyroid carcinoma. Troncone L; Rufini V; De Rosa G; Testa A Henry Ford Hosp Med J; 1989; 37(3-4):178-84. PubMed ID: 2576959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]